These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33932441)

  • 1. Comprehensive analysis of DNA damage repair in squamous cell carcinoma subtypes.
    Qin F; Sun Y; Deng K; Qin J; Xu Z; Wei J; Yuan L; Zheng T; Li S
    Life Sci; 2021 Aug; 278():119559. PubMed ID: 33932441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma.
    Yuan H; Qing T; Zhu S; Yang X; Wu W; Xu K; Chen H; Jiang Y; Zhu C; Yuan Z; Zhang T; Jin L; Suo C; Lu M; Chen X; Ye W
    Cancer Med; 2023 Apr; 12(8):10077-10090. PubMed ID: 36708047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of angiogenesis subtype of squamous cell carcinoma.
    Qin F; Lin S; Deng K; Qin J; Xu Z; Yuan L; Wei J; Sun Y; Zheng T; Li S
    World J Surg Oncol; 2021 Sep; 19(1):275. PubMed ID: 34521431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes.
    Vidotto T; Nersesian S; Graham C; Siemens DR; Koti M
    J Immunother Cancer; 2019 Jun; 7(1):148. PubMed ID: 31174611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Profiling of Lower-Grade Gliomas Subtype with Distinct Molecular and Clinicopathologic Characteristics via Altered DNA-Damage Repair Features.
    Maimaiti A; Liu Y; Abulaiti A; Wang X; Feng Z; Wang J; Mijiti M; Turhon M; Alimu N; Wang Y; Liang W; Jiang L; Pei Y
    J Mol Neurosci; 2023 May; 73(4-5):269-286. PubMed ID: 37067735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications.
    Jing X; Qin X; Liu H; Liu H; Wang H; Qin J; Zhang Y; Cao S; Fan X
    Eur J Med Res; 2024 Feb; 29(1):107. PubMed ID: 38326910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients.
    Zhang H; Deng YM; Chen ZC; Tang YC; Yang S; Zhang SD; Liang JM; Wang YG; Wu X; Zhang RW; Feng WN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7664-7672. PubMed ID: 32744692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
    Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
    JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Damage Repair Profiles Alteration Characterize a Hepatocellular Carcinoma Subtype With Unique Molecular and Clinicopathologic Features.
    Lin P; Gao RZ; Wen R; He Y; Yang H
    Front Immunol; 2021; 12():715460. PubMed ID: 34456923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
    Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
    Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer.
    Lou S; Wang Y; Zhang J; Yin X; Zhang Y; Wang Y; Xue Y
    Front Immunol; 2021; 12():806324. PubMed ID: 35082793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer.
    Dai J; Jiang M; He K; Wang H; Chen P; Guo H; Zhao W; Lu H; He Y; Zhou C
    Front Oncol; 2021; 11():708294. PubMed ID: 34604048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer.
    Tian W; Shan B; Zhang Y; Ren Y; Liang S; Zhao J; Zhao Z; Wang G; Zhao X; Peng D; Bi R; Cai S; Bai Y; Wang H
    Cancer Med; 2020 Mar; 9(6):2190-2200. PubMed ID: 31991061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a DNA damage repair gene-related signature for lung squamous cell carcinoma prognosis.
    Jia B; Gong T; Sun B; Zhang Z; Zhong D; Wang C
    Thorac Cancer; 2022 Apr; 13(8):1143-1152. PubMed ID: 35293140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery.
    Wang WT; Zhao YN; Yan JX; Weng MY; Wang Y; Chen YQ; Hong SJ
    J Hematol Oncol; 2014 Jan; 7():6. PubMed ID: 24405714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 shapes genome-wide and cell type-specific changes in microRNA expression during the human DNA damage response.
    Hattori H; Janky R; Nietfeld W; Aerts S; Madan Babu M; Venkitaraman AR
    Cell Cycle; 2014; 13(16):2572-86. PubMed ID: 25486198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
    Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
    J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Perspectives Reveal the Role of DNA Damage Repair Genes in the Molecular Classification and Prognosis of Pancreatic Adenocarcinoma.
    Li Y; Zhang K; Peng L; Chen L; Gao H; Chen H
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy.
    Ged Y; Chaim JL; DiNatale RG; Knezevic A; Kotecha RR; Carlo MI; Lee CH; Foster A; Feldman DR; Teo MY; Iyer G; Chan T; Patil S; Motzer RJ; Hakimi AA; Voss MH
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.